Plerixafor in non-Hodgkin’s lymphoma patients: a German analysis of time, effort and costs

por Hübel, Kai, Ostermann, H., Glaß, Bertram, Noppeney, Richard, Kron, Florian, Kron, Anna, Milkovich, Gary, Mohty, Mohamad
Publicado 2018

Improved survival with enasidenib versus standard of care in relapsed/refractory acute myeloid leukemia associated with IDH2 mutations using historical data and propensity score ma...

por de Botton, Stéphane, Brandwein, Joseph M., Wei, Andrew H., Pigneux, Arnaud, Quesnel, Bruno, Thomas, Xavier, Legrand, Ollivier, Recher, Christian, Chantepie, Sylvain, Hunault‐Berger, Mathilde, Boissel, Nicolas, Nehme, Salem A., Frattini, Mark G., Tosolini, Alessandra, Marion‐Gallois, Roland, Wang, Jixian J., Cameron, Chris, Siddiqui, Muhaimen, Hutton, Brian, Milkovich, Gary, Stein, Eytan M.
Publicado 2021